PT Metro Healthcare Indonesia Tbk (ISX:CARE) Moat Score: 0/10 (As of Jul. 11, 2026)


ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
79 GF Score
Price Rp426.00
GF Value Rp367.65
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk Moat Score?

PT Metro Healthcare Indonesia Tbk has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

PT Metro Healthcare Indonesia Tbk has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes PT Metro Healthcare Indonesia Tbk might have No Moat - No discernible moat.

PT Metro Healthcare Indonesia Tbk  (ISX:CARE) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

PT Metro Healthcare Indonesia Tbk Moat Score Related Terms

ISX:CARE
79GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp426.00 is trading 15.9% above its estimated GF Value™ of Rp367.65. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • Moat Score: 0
  • GF Value™: Rp367.65 vs. price of Rp426.00 (15.9% above fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
79GF Score

Get the complete analysis for ISX:CARE

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp426.00
Price
Rp367.65
GF Value